Enhanced Genomics Services For Chinese Researchers

WuXi’s customers can look forward to enhanced sequence analysis capabilities thanks to a partnership with NextCODE Health.

AsianScientist (Nov. 19, 2014) – WuXi PharmaTech Inc., an open-access R&D capability and technology platform company with operations in China and the United States, will provide Chinese researchers access to enhanced genomics services.

By making the integrated sequence analysis capabilities of NextCODE Health available to existing users of the WuXi Genome Center, WuXi’s customers will receive a report discussing the medical implication s of their gene sequencing data. This enhancement enables the research community to leverage the power of next generation sequencing and data analysis for better diagnosis and treatment of disease.

NextCODE offers the world’s only genome analysis system developed at population scale, with uniquely fast and proven capabilities for diagnosing rare diseases and gauging risk of common conditions.

——

Source: WuXi App Tech.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist